Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
|2||Enrolling by invitation||
Clinical and Virological Outcome of European Patients Infected With HIV
Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs
Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
† Study has passed its completion date and status has not been verified in more than two years.